Total Funding
61
55
Total FundingVenture - Series Unknown raised
Growth Score 61 in past quarter
-7 pts
Heat Score 55 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
73722
Saol Therapeutics is a biotech pharmaceutical company.
Acquired by 

Amneal Pharmaceuticals
- David Penake: CEO
Marion King: Senior Manager, Analytical & Formulation DevelopmentPast Role: Ipsen, Analytical Development Manager
About the Company
Saol Therapeutics is a biotech pharmaceutical company. At Saol Therapeutics, patients with diseases who are underserved for whatever reason are so much more than statistics. They are patients who deserve a chance at improved health. They are patients who need to be heard and who need to be helped. These patient populations with unmet needs are the
reason they are passionately committed to bringing therapies for serious and often life-threatening diseases and conditions to healthcare providers.